Literature DB >> 9442962

Imaging of nasopharyngeal carcinoma with Tc-99m MIBI.

M H Pui1, J Q Du, T C Yueh, S Q Zeng.   

Abstract

PURPOSE: Differentiation of recurrent nasopharyngeal carcinoma (NPC) from radiation fibrosis using conventional diagnostic methods can be difficult. The authors prospectively studied patients with NPC to determine the efficacy of Tc-99m MIBI scintigraphy in detecting the primary, residual, and recurrent tumors.
MATERIALS AND METHODS: The authors performed Tc-99m MIBI SPECT studies of the head and neck and whole-body scans on 21 healthy adult volunteers and 43 patients with NPC before (n = 26) or after (n = 17) radiotherapy. The images were qualitatively assessed by comparing the nasopharyngeal uptake to scalp radioactivity. MIBI uptake index was calculated as a ratio of mean counts per pixel in the normal nasopharynx or tumor to mean counts per pixel in the scalp.
RESULTS: There was significantly higher uptake of Tc-99m MIBI by NPC than normal nasopharynx and radiation fibrosis (P < .05). The authors determined the optimum cutoff MIBI uptake index value of 1.3 with a sensitivity of 97%, a specificity of 100%, a positive predictive value of 100%, a negative predictive value of 96%, and an accuracy of 98% for diagnosing NPC.
CONCLUSION: This study suggests that Tc-99m MIBI SPECT is useful for detecting primary NPC and for differentiating residual or recurrent tumor from radiation fibrosis. The authors propose the cutoff MIBI uptake index value of 1.3 for diagnosing NPC.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9442962     DOI: 10.1097/00003072-199801000-00009

Source DB:  PubMed          Journal:  Clin Nucl Med        ISSN: 0363-9762            Impact factor:   7.794


  3 in total

1.  Thymic carcinoid and parathyroid hyperplasia detection with 99mTc-MIBI men type 1.

Authors:  C Marí; J León; J Farrerons; X Matis-Guiu; A Tembl; J C Martin; A Flotats; L l Bernà
Journal:  J Endocrinol Invest       Date:  1999-11       Impact factor: 4.256

Review 2.  Nuclear medicine imaging for the assessment of primary and recurrent head and neck carcinoma using routinely available tracers.

Authors:  Hubert Vermeersch; David Loose; Hamphrey Ham; Andreas Otte; Christophe Van de Wiele
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-10-22       Impact factor: 9.236

Review 3.  Surveillance tools for detection of recurrent nasopharyngeal carcinoma: An evidence-based review and recommendations.

Authors:  Andrew Thamboo; Kim H Tran; Annette X Ye; Issraa Shoucair; Basel Jabarin; Eitan Prisman; Cathie Garnis
Journal:  World J Otorhinolaryngol Head Neck Surg       Date:  2022-04-21
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.